1.Discussion on the Chinese intellectual property rights and the protection of varieties of traditional Chinese Medicine
Chinese Journal of Biochemical Pharmaceutics 2014;(1):161-162
The problem of intellectual property of traditional Chinese medicine were discussed, the TCM protection system and patent protection system are studied. The author puts forward some deficiencies of the existing protection system, and puts forward some improvement methods possible.
4.Try to talk about knowledge yuan indexing in ancient books of traditional Chinese medicine clinical application of the literature indexing
International Journal of Traditional Chinese Medicine 2015;(4):296-298
Large number of TCM ancient books, the literature, has a long history and complicated contents, including the principles, methods, prescriptions, medicines and other various aspects. How to obtain and make use of knowledge in ancient books, we must establish a set of relatively precise knowledge and semantic relation networks. Knowledge yun performing reasonable rebuilding of TCM literature, containing much TCM knowledge and information, will be an important way for knowledge findings.
5.Clinical analysis of lingual tonsillar hypertrophy on 34 cases
Chinese Archives of Otolaryngology-Head and Neck Surgery 2001;8(2):76-77
Thirty-four patients with chronic lingual tonsillar hypertrophy were treated in our department from 1994 to 2000. There were 18 males and 16 females ranging in age from 21 to 60 years old. The clinical feature of lingual tonsillar hypertrophy usually appeared a series of pharyngeal symptoms, such as foreign-body sensation, sore throat, speech change, difficulty in swallowing, dysapnea and obstructive sleep apnea. The CO2 laser surgical lingual tonsillectomy was used for these patients. Result showed that the cure rate was 100% without any serious complications by following up 2 months to 3 years. The variety of presentations of lingual tonsillar hypertrophy and methods of surgical treament were discussed.
7.Enhencing awareness,identification and management of cataract surgery,improving comprehensive diagnosis and treatment ability of cataract
Chinese Journal of Experimental Ophthalmology 2016;34(3):193-198
Cataract is still the main blinding eye disease,and it is a major goal of fighting blindness in China.In the past years,the diagnosis,treatment technology and equipment have made great progress.With the further understanding of this disease and increasing requirement of patients for the quality of life,the standardization,safety and efficacy of the clinical diagnosis and surgical outcomes of cataract have become much more important.So the relative clinical examination approaches,modified operating skills,new surgery development and application as well as novel type of functional IOLs design advance rapidly,which provide an expensive space for the selection of the treatment for cataract.High quality of cataract surgery depends on preoperative precise biometry,reasonable operating scheme targeting at personality,suitable functional IOL,less intra-or post-operative complications,effectively avoiding treatment risk and correctly processing disadvantageous factors affecting postoperative visual quality.Therefore,the management of cataract surgery is a systemic procedure.The issue of improving ophthalmic examination,new cataract surgical technique and new IOL emerges as the time requires.How to make up individual-based treatment options for patients,better improve postoperative visual quality,enhance the safety of operative procedure,reduce operative complications is the challenges and unremitting goal for the ophthalmologists.
8.Research progress on risk factors of osteoporotic fractures in patients with rheumatoid arthritis
Chinese Journal of General Practitioners 2016;(2):152-155,156
Rheumatoid arthritis is a autoimmune diseases characterized as joint chronic synovitis, and is accompanied with systemic damage.Osteoporotic fracture is one of the common complications of rheumatoid arthritis, which may decrease quality of life, and even increase the mortality of patients.Variety of factors may be associated with the occurrence of osteoporotic fractures in rheumatoid arthritis patients.In this article, through the literature review we discuss the risk factors of osteoporotic fracture, including vitamin D deficiency, lower limb muscle strength and balance ability in rheumatoid arthritis patients.
9.Analysis of Labeled Items in Package Inserts of 51 Kinds of Ointment for External Use
China Pharmacy 2017;28(16):2286-2288
OBJECTIVE:To provide reference for reasonably designing package inserts of ointment for manufacturers. METH-ODS:According to items included in Management Regulation for Package Insert and Label and Specification for Chemicals and Bi-ological Products for Treatment,labeled items in package inserts of 51 kinds of ointment for external use during Jan.-Jun. 2016 in our hospital were analyzed. RESULTS:Among the 51 kinds of ointment,39 were domestic varieties and 12 were imported variet-ies. In the package inserts of 39 domestic varieties,items with lower labeling rates were overdose,pharmacokinetics,use guid-ance,pharmacology and toxicology,with labeling rates of 2.6%,5.1%,15.4%,28.2%;while the labeling rates of imported vari-eties were 16.7%,83.3%,75.0%,100%. Compared with package inserts of imported ointment,composition,dosage and usage, adverse reactions,contraindications,precautions,drug interactions,medication for special populations were not enough detailed in domestic ointments. CONCLUSIONS:It is suggested that manufacturers consult medicine experts, list all auxiliary materials through Management Regulation for Drug Description and Label,refine and improve the labeling contents of dosage and usage,ad-verse reactions,precautions,medication for special populations,pharmacology and toxicology,overdose,etc. In addition,admin-istrative departments should strengthen the regulatory approval efforts.
10.Research on factors restricting the development of pharmaceutical enterprises in our country and strategy
Chinese Journal of Biochemical Pharmaceutics 2014;(1):159-160,162
With chinese pharmaceutical companies in the rapid development, there are many factors restricting their development, this article through consulting relevant literature, data and investing, analyzing the shortage of the pharmaceutical enterprises at the present stage in China and the factors of restricting their development, so as to put forward the solution to the current situation of pharmaceutical enterprises in China and the related measures, make more long-term and healthy development of pharmaceutical enterprises in China.